Literature DB >> 7574531

Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii.

T J Walsh1, J Peter, D A McGough, A W Fothergill, M G Rinaldi, P A Pizzo.   

Abstract

In order to develop new approaches to treatment of infections due to Pseudallescheria boydii, the in vitro antifungal activity of amphotericin B alone and in combination with miconazole, itraconazole, and fluconazole was studied. Combinations of amphotericin B and antifungal azoles were synergistic, additive, or indifferent in their interaction against P. boydii. Antagonism was not observed.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7574531      PMCID： PMC162742          DOI： 10.1128/AAC.39.6.1361

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  24 in total

1.  Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi.

Authors:  A Espinel-Ingroff; T M Kerkering
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

2.  Pseudallescheria boydii infection of the central nervous system in a cardiac transplant recipient.

Authors:  S G Alsip; C G Cobbs
Journal:  South Med J       Date:  1986-03       Impact factor: 0.954

3.  Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole.

Authors:  S L Goldberg; D J Geha; W F Marshall; D J Inwards; H C Hoagland
Journal:  Clin Infect Dis       Date:  1993-06       Impact factor: 9.079

4.  Treatment failure in a case of fungal keratitis caused by Pseudallescheria boydii.

Authors:  P A Bloom; D A Laidlaw; D L Easty; D W Warnock
Journal:  Br J Ophthalmol       Date:  1992-06       Impact factor: 4.638

5.  Fungal endocarditis caused by Pseudallescheria (Petriellidium) boydii in an intravenous drug abuser.

Authors:  A R Armin; V B Reddy; E Orfei
Journal:  Tex Heart Inst J       Date:  1987-09

6.  Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi.

Authors:  A Espinel-Ingroff; K Dawson; M Pfaller; E Anaissie; B Breslin; D Dixon; A Fothergill; V Paetznick; J Peter; M Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

7.  The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis.

Authors:  A Schaffner; P G Frick
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

Review 8.  Central nervous system infection caused by Pseudallescheria boydii: case report and review.

Authors:  J Berenguer; J Diaz-Mediavilla; D Urra; P Muñoz
Journal:  Rev Infect Dis       Date:  1989 Nov-Dec

9.  Pseudallescheria boydii brain abscess. Complication of an intravenous catheter.

Authors:  R E Pérez; M Smith; J McClendon; J Kim; N Eugenio
Journal:  Am J Med       Date:  1988-02       Impact factor: 4.965

Review 10.  Pseudallescheria boydii endocarditis of the pulmonic valve in a liver transplant recipient.

Authors:  F K Welty; G X McLeod; C Ezratty; R W Healy; A W Karchmer
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079
View more
  32 in total

Review 1.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans.

Authors:  J Meletiadis; J W Mouton; J L Rodriguez-Tudela; J F Meis; P E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.

Authors:  Fèlix Gilgado; Carolina Serena; Josep Cano; Josepa Gené; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2006-10-02       Impact factor: 5.191

4.  Fatal Scedosporium prolificans infection in a leukemic patient.

Authors:  M C Feltkamp; M J Kersten; J van der Lelie; J D Burggraaf; G S de Hoog; E J Kuijper
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-06       Impact factor: 3.267

5.  Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models.

Authors:  F C Odds; F Van Gerven; A Espinel-Ingroff; M S Bartlett; M A Ghannoum; M V Lancaster; M A Pfaller; J H Rex; M G Rinaldi; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

6.  Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi.

Authors:  A Espinel-Ingroff; M Bartlett; R Bowden; N X Chin; C Cooper; A Fothergill; M R McGinnis; P Menezes; S A Messer; P W Nelson; F C Odds; L Pasarell; J Peter; M A Pfaller; J H Rex; M G Rinaldi; G S Shankland; T J Walsh; I Weitzman
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

7.  Oral terbinafine for treatment of pulmonary Pseudallescheria boydii infection refractory to itraconazole therapy.

Authors:  P E Verweij; N J Cox; J F Meis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

8.  Fungicidal activity of cecropin A.

Authors:  A J DeLucca; J M Bland; T J Jacks; C Grimm; T E Cleveland; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

9.  Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole.

Authors:  Eric Nulens; Cathrien Eggink; Antonius J M M Rijs; Pieter Wesseling; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

Review 10.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.